ImmunoGen Inc (IMGN)

[skitahoe]

On the I-V board I just had an exchange with a technically knowledgeable poster medically who believes the weakness was created by the results in Bayer's drug. If so, I believe it's a huge overreaction, but it's clear that Bayer has not given up on the drug, but the registrational Phase 2 Trial was an attempt at rapid approval which failed.

To me, the real value in IMGN is it's drugs, the others help fund the company, but the big profits will come from it's drugs achieving approval. Of course IMGN will establish ROW partnerships at some point. They've already done this with Jazz in development of their newest IGN based drugs, but as long as results remain positive, it's IMGN853 that should bring in very big money in a ROW partnership, and the drug should eventually have blockbuster potential in the U.S. alone, where it intends to maintain full ownership.

Gary